CVS · 10-Q · 2026Q2 · Full report

Interest Rate and Refinancing Exposure

CVS HEALTH Corp · 2026-08-05 · Importance 29 · Surprise 24

As of June 30, 2026, CVS Health’s long-term debt was rated “BBB” by Fitch, “Baa3” by Moody’s and “BBB” by S&P. Fitch maintained a “Negative” outlook, while Moody’s outlook was “Stable” and S&P changed its outlook from “Negative” to “Stable” in May 2026. The Company believes its long-term debt ratings will remain investment grade but cannot predict future rating actions. Debt ratings directly affect future borrowing costs, access to capital markets and new store operating lease costs.

Key facts

• Interest expense for the three months ended June 30, 2026 was $757 million. source